Clinical Trial

Probiotic Use for Recovery Enhancement From Long COVID-19

Name: Probiotic Use for Recovery Enhancement From Long COVID-19 — clinical trial record (NCT06643299)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PURE-LC

Completed Phase 2

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to learn if probiotics can improve symptoms and quality of life in participants with Long COVID.

Protocol Amendment History 2 changes

critical Trial completed 2026-08-08

notable Primary completion pushed: 2026-05 -> 2026-07-02 2026-08-08

Trial Details

NCT Number	NCT06643299
Lead Sponsor	Rush University Medical Center
Conditions	Post-Acute COVID-19 Syndrome
Enrollment	194 participants
Start Date	2025-05-13
Primary Completion	2026-07-02 (estimated)
Study Completion	2026-07-02 (estimated)
Updated on ClinicalTrials.gov	2026-08-07